AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies.

Maria R Abbattista, Stephen M F Jamieson, Yongchuan Gu, Jennifer E Nickel, Susan M Pullen, Adam V Patterson, William R Wilson, Christopher P Guise, Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma. Cancer Biology & Therapy. ,vol. 16, pp. 610- 622 ,(2015) , 10.1080/15384047.2015.1017171

Michael J Lewis, John P Wiebe, J Godfrey Heathcote, Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer. ,vol. 4, pp. 27- 27 ,(2004) , 10.1186/1471-2407-4-27

T Barrette, A Pandey, AM Chinnaiyan, ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform Neoplasia. ,vol. 6, pp. 1- 6 ,(2004) , 10.1016/S1476-5586(04)80047-2

Tea Lanišnik Rižner, Trevor M. Penning, Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism. Steroids. ,vol. 79, pp. 49- 63 ,(2014) , 10.1016/J.STEROIDS.2013.10.012

Roniel Cabrera, Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepatic Medicine : Evidence and Research. ,vol. 4, pp. 19- 37 ,(2012) , 10.2147/HMER.S16316

Wei Xiong, Jing Zhao, Hongliang Yu, Xiaoying Li, Shaoqian Sun, Yi Li, Qing Xia, Chuanling Zhang, Qiuchen He, Xianshu Gao, Lihe Zhang, Demin Zhou, Elevated Expression of AKR1C3 Increases Resistance of Cancer Cells to Ionizing Radiation via Modulation of Oxidative Stress PLoS ONE. ,vol. 9, pp. e111911- ,(2014) , 10.1371/JOURNAL.PONE.0111911

Tara Behne, M. Sitki Copur, Biomarkers for hepatocellular carcinoma. International journal of hepatology. ,vol. 2012, pp. 859076- 859076 ,(2012) , 10.1155/2012/859076

Elisa Wurmbach, Ying‐bei Chen, Greg Khitrov, Weijia Zhang, Sasan Roayaie, Myron Schwartz, Isabel Fiel, Swan Thung, Vincenzo Mazzaferro, Jordi Bruix, Erwin Bottinger, Scott Friedman, Samuel Waxman, Josep M Llovet, None, Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma Hepatology. ,vol. 45, pp. 938- 947 ,(2007) , 10.1002/HEP.21622

Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F Berger, John E Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané-Valbuena, Felipa A Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H Engels, Jill Cheng, Guoying K Yu, Jianjun Yu, Peter Aspesi, Melanie De Silva, Kalpana Jagtap, Michael D Jones, Li Wang, Charles Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C Onofrio, Ted Liefeld, Laura MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P Mesirov, Stacey B Gabriel, Gad Getz, Kristin Ardlie, Vivien Chan, Vic E Myer, Barbara L Weber, Jeff Porter, Markus Warmuth, Peter Finan, Jennifer L Harris, Matthew Meyerson, Todd R Golub, Michael P Morrissey, William R Sellers, Robert Schlegel, Levi A Garraway, None, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature. ,vol. 483, pp. 603- 607 ,(2012) , 10.1038/NATURE11003

Ting Zhong, Feifei Xu, Jinhui Xu, Liang Liu, Yun Chen, Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN Loss Biomedicine & Pharmacotherapy. ,vol. 69, pp. 317- 325 ,(2015) , 10.1016/J.BIOPHA.2014.12.022